Kidney exchange transplantation is well established modality to increase living donor kidney transplantation.
INTRODUCTION
Chronic kidney disease is the global health problem with high prevalence rate of 11% to 13% [1, 2] . Outcome of living donor kidney transplantation is two times better than deceased donor kidney transplantation. Kidney exchange transplantation is well established modality to increase living donor kidney transplantation and more useful in countries where deceased donor kidney transplantation is not well developed. Kidney ex change transplantation provides good quality of organs and increasingly used in developed [310] and developing world [1123] . Kidney exchange is more useful in countries with low deceased donation rates (China, South, Korea, Japan, India and Pakistan) due to cultural and regional factors. Reasons for joining kidney exchange programs are ABO blood group incompatibility, imm unological incompatibility (positive cross match or do nor specific antibody), human leukocyte antigen (HLA) incompatibility (poor HLA matching), chronological incompatibility and financial incompatibility. Kidney exchange transplantation has evolved from the traditional simultaneous anonymous 2way kidney exchange to more complex ways. Table 1 shows types of kidney exchange. Table 2 shows key features of success in single center kidney exchange program in india. Table 3 shows key features of national kidney exchange program. Table 4 shows strength and weakness of international kidney Exchange. There is limited solution to O blood group patients with nonO donor and highly sensitized pairs in kidney exchange program due to blood group composition of the general and end stage kidney di sease population [24] . International kidney exchange transplantation in a global environment of regulation imposed by World Health Organization and the Tran splantation Society could increase transplantation for difficult to match donorrecipient pairs such as highly sensitized pairs and O blood group patients with nonO donor [2528] . The heterogeneity in antigen antibody
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profile and blood group composition in different geog raphic area may be contributing factor for this incre ased transplant rate. International kidney exchange transplantation should be reviewed by the ethics com mittee according to international standards of Good Clinical Practice and as per local laws and regulations. It should be also abided by the Declaration of Helsinki and Declaration of Istanbul principles. National kidney exchanged may be first attempted to keep the logistics simple before participation in International kidney exchange transplantation. More studies are required about willingness of donorrecipient pairs, transplant professionals and society to participate in such kind on program in ethical and regulatory environment. There should be collaboration in the adjutant National kidney exchange registries in initial pilot project.
THREE CATEGORIES OF ADVANCED DONATION PROGRAM
Ethical concerns about advanced donation program include the management of uncertainty, the extent of donor and recipient consent, the scope of the obligation that the organization has to the kidney exchange recipient, and the potential to unfairly advantage the recipient [2931] . Butt et al [32] reported "outofsequence donation"
in which a donor donates in kidney exchange chain early because of time limits and their intended paired recipient receives a kidney transplant a short time later. The patient is already having identified matched kidney exchange donor but transplant could not be completed for whatever reason. The donating pair has to take calculated risk that other pairs will actually donate the kidney in short time. Flechner et al [33] reported "short term unmatched" donation in which recipient without a match at the time of his donation, was matched and transplanted few months later. The recipient then gets priority to be matched for a kidney. Veale et al [34] reported first case of "voucher" do nation in which a living donor donates a kidney to re ceive voucher for a intended named patient to be tran splanted in the near future. Vouchers can be used for future kidney transplants to overcome "chronological incompatibility" between living donors and recipients in the modern era of living donor banking. However an exact time limit for matching cannot be guaranteed. The detailed written informed consent process of ad vance donation program should include the alternatives such as living donation, deceased donation, nonsim ultaneous extended altruistic donor chain and waiting until a transplant is indicated.
DECEASED DONORS AS A SOURCE OF CHAIN INITIATING KIDNEYS
Melcher et al [35] reported that deceased donor kidney can be used to start nonsimultaneous extended alt ruistic donor chain. Standard criteria deceased donor kidney or deceased donor with kidney donor profile index below 35 should be used for optimum outcome.
DONOR RENEGE MYTH OR REALITY
It was standard practice to do surgery simultaneously when kidney exchange was started in 1986 in the tr aditional simplest form of 2way exchange. [36] reported a realworld renege rate of 1.5% and realtime swap failures as a subset of broken chains in 35% of cases in analysis of 1748 kidney exchange transplants from the National Kidney Registry from 2008 through May 2016. Gentry et al [37] estimated a bridge donor renege rate of 5% per month for nonsimultaneous extended altruistic donor chains. The simulation was then run over 24 mo and resulted in 35% of chains broken by donor reneging, significantly higher than by recent study Cowan et al [36] of 1.7%. The data from India also reported donor renege rate of zero percent in single center study of 300 kidney exchange transplants. It shows that donor renege is rare and is not significant problem in modern kidney exchange practice.
PROS AND CONS OF ANONYMITY

IN DEVELOPED WORLD AND (NON-)
ANONYMITY IN DEVELOPING WORLD
There is disparity on standard practice of kidney exc hange in developed and developing World in term of (non) anonymity. There is variable practice on anon ymity before and after surgery in different countries. Conditional approach [38] : When the donorrecipient pairs give consent for meeting after surgery, they are allowed to meet each other after surgery in some countries such as the United States of America [39] and the United Kingdom [40] . In other countries, such as the Netherlands and Sweden [41] , anonymity is absolute. Anonymity protects patients, donors and transplant hospital/ administration against the risks of revoking anonymity and prevents further commercialization of organs, and breach of patient donor privacy. An Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), a subsection of the European Society for Organ Transplantation reported that a conditional approach to anonymity should be possible after surgery [42] . Pronk et al [38] showed that most donorrecipient pairs who participated in anonymous donation process are in favour of a conditional approach to anonymity. Guidelines on how to revoke anonymity if both parties agree are ne eded and should include education about pros and cons of (non) anonymity and a logistical plan on how, when, where, and by whom anonymity should be revoked. Nonanonymous allocation [11, 12] : Donorrecipient pa 54 WJT|www.wjgnet.com
Table 1 Types of kidney exchange
Simultaneous anonymous 2-way kidney exchange 3-way, 4-way, n-way exchange
PROS AND CONS OF DONOR TRAVEL
VS KIDNEY TRANSPORT [43] [44] [45] [46] [47] [48] The cold ischemia time is more detrimental in dec eased donor kidney transplant than live donor kidney transplant. There is no statistically significant difference in live donor kidney transplant survival in shipped vs nonshipped kidney in data from various National re gistries (Scientific Registry of Transplant Recipients registry in the United States, National Kidney Registry in the United States, and Australian kidney paired donation program). This is feasible strategy to improve the quality of matching such as HLA matching in ki dney exchange program. However, more studies are required to define long term safety of shipping donor kidneys and willingness of donorrecipient pairs to pa rticipate in donor travel vs kidney transport
In Canada with wide geographic distribution, donor travel is accepted and preferred over kidney transport whereas, in Australia kidney transport is accepted and preferred over donor travel.
Disadvantages of donor travel are variation in donor irs are allowed to meet each other before allocation of donor for surgery and even after surgery. They can sh are medical reports of exchange donors before surgery and kidney transplant and donor surgery outcome after surgery. Donorrecipient pairs do not choose their match but donorrecipient pairs may decline a match or can withdraw from participation in the kidney exchange program at any time, for any reason. Nonanonymous allocation has the potential of commercialization of organs in case of compatible donorrecipient pairs along with breach in privacy of donorrecipient pairs. Kute et al [11, 12] reported that donorrecipient pairs are willing for nonanonymous allocation process in single center study of 300 kidney exchange transplants in India. They reported that nonanonymity is more helpful in manual allocation in absence of computer software allocation which also increases trust between patients, donors and transplant hospital/administration and legal team. More long term prospective studies are required to explore the donor and recipient perspective on anonymity in living kidney donation in different socioeconomic re gions and countries. Advantages of kidney transport are familiarity with the transplant team, presence of family and friends for logistical support. Disadvantage of kidney transport is the effect of prolong cold ischemia time on long term kidney allograft survival. However recent studies have shown that cold ischemia time of 16 h has minimal/ no effect on long term kidney allograft survival. Cold ischemia time is short in kidney exchange programs where donor travel is used. The Global Positioning System tracking devices can be used to monitor the location of shipped kidneys. Donorrecipient pairs should discuss the best option with the transplant team as per available resources. The participating transplant teams should make the decision by consensus about kidney donor travel vs kidney transport as per local resources and logistics. Donor travel rather than kidney transport is likely to be logistically simpler to execute in the Indian situation.
EDUCATION, AWARENESS AND
COUNSELLING OF INCOMPATIBLE DONOR-RECIPIENT PAIRS
Variations in practice for management of incompatible donorrecipient pairs will inevitably occur when clinicians take into account the needs of individual patients, av ailable resources, and limitations unique to a clinical situation. There is need of clinical practice guideline document to be designed to provide information and assist decisionmaking in relation to kidney exchange vs desensitization. Each donorrecipient pairs should be given education, awareness, and counselling about risk, benefits and cost effectiveness of various renal replacement therapy options (ABO incompatible kid ney transplantation vs kidney exchange, deceased donor kidney transplantation and dialysis) in an easy to understand format as early as possible in process of chronic kidney disease evaluation, treatment and tra nsplant evaluation. This counselling can be performed by member of transplant team during dialysis ses sions. Patients were encouraged for living donor kid ney transplantation over deceased donor kidney tra nsplantation. Patients with incompatible living donors should be encouraged for kidney exchange and ABO incompatible kidney transplantation depending on their phenotype. Infection is common cause of morbidity and mortality after kidney transplantation in developing world compared to developed world.
NEED OF ALGORITHM FOR
MANAGEMENT OF INCOMPATIBLE DONOR-RECIPIENT PAIRS
The match/transplant rates for nonO group patients are higher with kidney exchange compared to O group patients. Such easy to match pairs (nonO group patients such as A donor and B recipient; B donor and A recipient and sensitised pairs) should be encouraged for kidney exchange over ABO incompatible kidney transplantation and desensitization protocol [11, 12, 49] . O group patients with ABO titer ≤ 128 or panel reactive antibody > 80% should undergo desensitization and ABO incompatible kidney transplantation with acc eptable outcome [49] . O group patients with ABO titer > 128 should be first considered in kidney exchange than ABO incompatible kidney transplantation [49] . If no Kute VB et al . Kidney exchange transplantation match is found with kidney exchange in a reasonable period of time they can be undergo ABO incompatible kidney transplantation with equally good results but with greater number of treatments and cost. For sensitized donorrecipient pairs who have ph enotypes that are either easytomatch and/or difficult todesensitize are more likely to benefit from kidney exchange, whereas those who are either easytodes ensitize and/or difficulttomatch should be considered for desensitization. For sensitized donorrecipient pairs with phenotypes that are both difficulttodesensitize and difficulttomatch may benefit from a combination of kidney exchange and desensitization in which they are paired with a more immunologically suitable donor [49] . This will reduce waiting time for deceased donor kidney transplantation for patients with no living kidney donor. ABO incompatible kidney transplantation should continue to function in a complimentary way that enhances ac cess to living donor kidney transplantation rather than competes with kidney exchange. ABO incompatible kidney transplantation should be performed after ob taining written informed consent of donorrecipient pa irs. Patients with economic constrains; pretransplant infections and baseline high ABO titer may be excluded from ABO incompatible kidney transplantation. Table 5 Shows Advantages of Global Kidney Exchange (GKE). Figure 1 shows Stepwise Progress in Kidney Exchange. One third of donorrecipient pairs could not receive kidney transplantation due to immunological incompatibility (ABO incompatible or positive cross match/donor specific antibody). Financial incompatibility is much more common barrier to kidney transplantation than immunological incompatibility in developing cou ntries in absence of universal access to health care for endstage renal disease. Global kidney exchange increases access to living donor kidney transplantation for donorrecipient pairs from developing countries with financial incompatibility [50, 51] . Global kidney exchange should be conducted in legal, transparent and an ethical way. Global kidney exchange will help rich donorrec ipient pairs from developed countries with universal access to health care for endstage renal disease and poor donorrecipient pairs from developing countries in absence of universal access to health care for endstage renal disease. It should run in a way that enhances access to living donor kidney transplantation with ki dney exchange along with national and regional KPD program. The collaboration of single center, regional, National, International and Global kidney exchange program should aim to provide cost effective kidney transplantation with better long term outcome for all pa tients with endstage renal disease.
PROS AND CONS OF GLOBAL KIDNEY EXCHANGE
We believe that single center, regional, National kidney exchange program should be attempted before International and Global kidney exchange program to overcome transcultural and logistical issues with the later [52, 53] . In addition, more studies are required for the definition of financial incompatibility and about willingness and feasibility of donorrecipient pairs from developing countries for International and Global kidney exchange program. Clearly, the heterogeneity in antigenantibody profile of donorrecipient pairs from developing countries and developed countries increase Table 5 Advantages of global kidney exchange [50] [51] [52] [53] 2-7 million people die World-wide from kidney failure due to poverty. Helping some of these poor patients would be good. GKE helps only those patients who have exhausted all the solutions in their home country and increases transplant opportunity for poor patients from low/middle income countries who are otherwise exposed to death [61] [62] GKE wants to support poor patients from low/middle income country legally, ethically, fairly and transparently following the rules established by the National Competent Authorities of each country GKE does not induce donation but removes the financial barrier to donation for a willing donor recipient pairs where donor's motivation is altruistic and unpaid Everybody wins in GKE: Low/middle income country's donor and recipient, low/middle income country's pre-and post-transplantation health care system, high income country's recipient, health care payers and high income country's Government and taxpayers GKE can send high income country patient to high quality low/middle income country transplant centers, instead of reverse. This would be less expensive and build local infrastructure in low/middle income country and access to kidney transplantation to more low/middle income country patients There can be oversight by organizations such as the World Health Organization and the Transplantation Society with strong International governance that is consistent with the highest ethical and legal standards GKE: Global kidney exchange.
Kidney exchange should be available at each transplantation unit across the world to achieve the goal of "transplant for all" Kute VB et al . Kidney exchange transplantation access to living donor kidney transplantation for difficult to match and highly sensitised donorrecipient pairs. The larger donor pool in International kidney exchange will increase HLA matching of donorrecipient pairs which is the best parameter to improve long term kidney graft survival. Global kidney exchange appears to provide lifesaving kidney transplantation to poor donorrecipient pairs from developing countries that otherwise could die due to economic constrain [5053] .
PAIRED EXCHANGE TO INCREASE LIVING DONOR LIVER TRANSPLANTATION
An exchange donor program for adult living donor liver transplantation appears to be a feasible modality for overcoming donorrecipient ABO incompatibility [5456] .
FUTURE OF ORGAN TRANSPLANTATION IN RESOURCE-LIMITED SETTING: LIVER
VS KIDNEY EXCHANGE: LEGITIMATE HOPE OR UTOPIA?
Opportunity and necessity is the mother of invention. Suppose, there are two patients in developing countries with end stage kidney disease and end stage liver disease with no suitable living donors in family in area without deceased donor organ transplantation. The morbidity and mortality of end stage kidney disease and end stage liver disease is very high in developing countries in absence of national health care insurance, deceased donor organ transplantation program and economic constrains. The organ trafficking is regularly reported in media in underdeveloped World. There is no other outcome for these patients other than death if they did not undergo organ transplantation. The life of these patients can be saved by exchanging liver of patient with end stage kidney disease with kidney of patient with end stage liver disease with optimum patient care before organ harvesting. There is no better solution for such kind of patients other than ex change of organs (liver vs kidney). The patient who participate in such exchange should be medically, ps ychosocially suitable, fully informed of the risks and benefits as a donor, competent, willing to donate and free of coercion. Let us be clear: The intention of such kind of exchange is to save human life and without exchange of organs (liver vs kidney) such patients will never going to receive organ transplantation. No alternative existed for such patients and millions more like them. Such organ exchange even if inequitable would able to add years of life to patients who would have died without it.
The mortality rate is at least 10 times higher in living donor liver donation with mortality rate of 0.5% than living donor kidney donation with mortality rate of 0.03% [5759] . The morbidity rate of 20% is also higher in living donor liver donation. There is regeneration of liver and not kidney in short period. The health care providers from developing and developed World incl uding policy makers should come together to discuss challenges and solution to solve the disparity in access to organ transplantation in developing and developed World. This will be great service to mankind who are in real need. More discussion and studies are required for patient/donor selection, professional /public acceptance, legislation, logistics, exploitations, equity and ethical issues for such kind of organ exchanges in near future to solve the global problem of organ shortage especially in developing world on the International platform such as the World Health Organization and The Transplantation Society. This could be an alternative to xenotransplantation and may serve as Nobel service to Mankind.
CONCLUSION
Kidney exchange transplantation has increased living donor kidney transplantation for end stage renal disease patients with chronological incompatibility and financial incompatibility. The participating transplant teams and donorrecipient pairs should make the decision by consensus about kidney donor travel vs kidney tr ansport and anonymity vs nonanonymity in allocation as per local resources and logistics. There is need of uniform algorithm for management of incompatible donorrecipient pairs. 
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